Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.23 is 75% below its 5-year average of 4.83, near the low end of its 5-year range (1.23–6.92).
As of the fiscal period ended Tuesday, June 30, 2026. 57.24% below its 12-month average of 2.87.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.23.
CURRENT RATIO
1.23
CURRENT RATIO AVG TTM
2.87
CURRENT RATIO AVG 3Y
3.82
CURRENT RATIO AVG 5Y
4.83
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-57.24%
CURRENT VS 3Y AVG
-67.90%
CURRENT VS 5Y AVG
-74.60%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.08
median of 374 covered companies
CURRENT VS SECTOR MEDIAN
-60.09%
vs the sector median at left
Market Cap
$12.89B
Current Ratio
0.95
TTM Avg
1.18
3Y Avg
1.19
5Y Avg
1.30
Market Cap
$13.19B
Current Ratio
2.86
TTM Avg
3.13
3Y Avg
4.39
5Y Avg
5.54
Market Cap
$12.52B
Current Ratio
1.95
TTM Avg
1.83
3Y Avg
1.71
5Y Avg
1.91
Market Cap
$12.17B
Current Ratio
1.59
TTM Avg
1.45
3Y Avg
1.38
5Y Avg
1.43
Market Cap
$12.00B
Current Ratio
1.19
TTM Avg
1.06
3Y Avg
1.17
5Y Avg
1.20
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | $12.95B | 1.23 | 2.87 | 3.82 | 4.83 |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 0.95 | 1.18 | 1.19 | 1.30 |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 2.86 | 3.13 | 4.39 | 5.54 |
| Baxter International Inc. (BAX)vs › | $12.52B | 1.95 | 1.83 | 1.71 | 1.91 |
| Penumbra, Inc. (PEN)vs › | $12.49B | 5.75 | 6.32 | 5.98 | 5.88 |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.17B | 1.59 | 1.45 | 1.38 | 1.43 |
| Encompass Health Corporation (EHC)vs › | $12.00B | 1.19 | 1.06 | 1.17 | 1.20 |
| Ascendis Pharma A/S (ASND)vs › | $14.16B | 2.99 | 1.10 | 1.11 | 4.42 |
| DaVita Inc. (DVA)vs › | $11.47B | 1.47 | 1.27 | 1.23 | 1.26 |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 4.55 | 4.00 | 4.18 | 3.92 |
Current Ratio
1.23
Quick Ratio
1.17
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.23 |
| 2026-03-31 | 1.44 |
| 2025-12-31 | 2.62 |
| 2025-09-30 | 3.88 |
| 2025-06-30 | 5.19 |
| 2025-03-31 | 4.57 |
| 2024-12-31 | 4.67 |
| 2024-09-30 | 3.19 |
| 2024-06-30 | 4.59 |
| 2024-03-31 | 5.54 |
| 2023-12-31 | 3.32 |
| 2023-09-30 | 5.54 |
| 2023-06-30 | 3.93 |
| 2023-03-31 | 5.72 |
| 2022-12-31 | 4.52 |
| 2022-09-30 | 5.39 |
| 2022-06-30 | 5.46 |
| 2022-03-31 | 6.92 |
| 2021-12-31 | 6.58 |
| 2021-09-30 | 6.68 |
| 2021-06-30 | 6.90 |
| 2021-03-31 | 9.98 |
| 2020-12-31 | 6.72 |
| 2020-09-30 | 9.85 |
| 2020-06-30 | 9.30 |
| 2020-03-31 | 14.25 |
| 2019-12-31 | 9.42 |
| 2019-09-30 | 14.00 |
| 2019-06-30 | 7.92 |
| 2019-03-31 | 10.78 |
| 2018-12-31 | 13.67 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
